Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-10 Purchase | 2023-11-13 5:29 pm | Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair | 25,000 | $2.9638 | $74,095 | 261,966 (Direct) | View |
| 2023-05-31 Purchase | 2023-06-02 4:15 pm | Lyra Therapeutics Inc. | LYRA | NBVM GP LLC DAMORE RICHARD A NORTH BRIDGE VENTURE PARTNERS V A LP NORTH BRIDGE VENTURE PARTNERS V-B LP North Bridge Venture Partners VI L P North Bridge Venture Management V L.P. North Bridge Venture Management VI L.P. 10% Owner | 1,805,416 | $2.43 | $4,387,161 | 3,424,453 (Indirect) | View |
| 2023-05-31 Purchase | 2023-06-02 4:11 pm | Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner | 1,805,416 | $2.43 | $4,387,161 | 3,542,936 (Indirect Direct) | View |
| 2023-05-31 Purchase | 2023-06-02 4:11 pm | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 3,610,832 | $2.4925 | $8,999,999 | 14,562,979 (Indirect) | View |
| 2022-06-10 Purchase | 2022-06-13 4:05 pm | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 4,000 | $5.05 | $20,200 | 11,328 (Direct) | View |
| 2022-05-13 Purchase | 2022-05-17 5:35 pm | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 3,828 | $4.829 | $18,486 | 7,328 (Direct) | View |
| 2022-04-12 Purchase | 2022-04-14 4:53 pm | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 5,924,170 | $4.22 | $24,999,997 | 9,146,731 (Indirect) | View |
| 2022-04-12 Purchase | 2022-04-14 4:14 pm | Lyra Therapeutics Inc. | LYRA | NBVM GP LLC DAMORE RICHARD A NORTH BRIDGE VENTURE PARTNERS V A LP NORTH BRIDGE VENTURE PARTNERS V-B LP North Bridge Venture Partners VI L P North Bridge Venture Management V L.P. North Bridge Venture Management VI L.P. 10% Owner | 2,369,667 | $4.22 | $9,999,995 | 1,318,133 (Indirect) | View |
| 2022-04-12 Purchase | 2022-04-14 4:08 pm | Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner | 2,488,150 | $4.22 | $10,499,993 | 1,436,616 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-18 Option Award | 2024-03-20 7:21 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair | 275,000 | $0 | 536,966 (Direct) | View |
| 2024-03-18 Option Award | 2024-03-20 7:20 pm | N/A 2034-03-17 | Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO | 500,000 | $0 | 500,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 4:15 pm | N/A 2034-01-29 | Lyra Therapeutics Inc. | LYRA | Bishop John E Chief Technology Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 4:15 pm | N/A 2034-01-29 | Lyra Therapeutics Inc. | LYRA | Nieman Richard Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2024-01-30 Option Award | 2024-02-01 4:15 pm | N/A 2034-01-29 | Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-06-15 Option Award(A) | 2023-07-12 6:36 pm | N/A 2033-06-14 | Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:53 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | TOBIN JAMES R Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:52 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:50 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:49 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:49 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:46 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-05 9:46 pm | N/A 2033-06-29 | Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-26 5:39 pm | N/A 2023-06-14 | Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-27 Option Award | 2023-02-28 4:10 pm | N/A 2033-02-26 | Lyra Therapeutics Inc. | LYRA | Bishop John E Chief Technology Officer | 220,000 | $0 | 220,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:41 pm | N/A 2033-01-30 | Lyra Therapeutics Inc. | LYRA | Richard Robert E. SVP, Technical Operations | 75,000 | $0 | 75,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:19 pm | N/A 2033-01-30 | Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair | 200,000 | $0 | 200,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:12 pm | N/A 2033-01-30 | Lyra Therapeutics Inc. | LYRA | Noyes Corinne See Remarks | 91,667 | $0 | 91,667 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:11 pm | N/A 2033-01-30 | Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:09 pm | N/A 2033-01-30 | Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO | 250,000 | $0 | 250,000 (Direct) | View |
| 2023-01-31 Option Award | 2023-02-02 5:08 pm | N/A 2033-01-30 | Lyra Therapeutics Inc. | LYRA | Nieman Richard Chief Medical Officer | 55,537 | $0 | 55,537 (Direct) | View |
| 2022-07-11 Option Award | 2022-07-12 4:10 pm | N/A 2032-07-10 | Lyra Therapeutics Inc. | LYRA | Nieman Richard Chief Medical Officer | 230,000 | $0 | 230,000 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:06 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair | 953,002 | $0 | 953,002 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:05 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner | 7,250 | $0 | 7,250 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-21 4:05 pm | N/A 2032-06-15 | Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director | 7,250 | $0 | 7,250 (Direct) | View |